Synopsis

MR imaging plays an invaluable role for the non-invasive assessment of diffuse liver diseases and for detecting and characterizing focal liver lesions, frequently avoiding liver biopsies. Diffuse liver diseases may result from metabolic, alcoholic, viral, toxic, or genetic disorders. In these patients, quantification of hepatic fat, iron and fibrosis is crucial for the diagnosis, treatment monitoring and follow-up. The end-stage of diffuse liver diseases is liver cirrhosis, which can be diagnosed by MR imaging. On the other hand, MR imaging is the cornerstone for the characterization of benign and malignant focal liver lesions, being crucial for the optimal patient management.

Acknowledgements

References